[go: up one dir, main page]

WO2003083048A3 - Novel secreted proteins and their uses - Google Patents

Novel secreted proteins and their uses Download PDF

Info

Publication number
WO2003083048A3
WO2003083048A3 PCT/US2003/006714 US0306714W WO03083048A3 WO 2003083048 A3 WO2003083048 A3 WO 2003083048A3 US 0306714 W US0306714 W US 0306714W WO 03083048 A3 WO03083048 A3 WO 03083048A3
Authority
WO
WIPO (PCT)
Prior art keywords
secreted proteins
novel secreted
useful
nucleic acids
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2003/006714
Other languages
French (fr)
Other versions
WO2003083048A2 (en
Inventor
Margret Barbara Di Basinski
Rueben Kirobi Njau
Douglas Raymond Perkins
Ho Yeong Song
Eric Wen Su
Yu Zhi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Priority to EP03745524A priority Critical patent/EP1492558A4/en
Priority to AU2003216525A priority patent/AU2003216525A1/en
Publication of WO2003083048A2 publication Critical patent/WO2003083048A2/en
Publication of WO2003083048A3 publication Critical patent/WO2003083048A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The present invention provides nucleic acid sequences encoding novel human proteins. These novel nucleic acids are useful for constructing the claimed DNA vectors and host cells of the invention and for preparing the claimed nucleic acids, recombinant proteins and antibodies that are useful in the claimed methods and medical uses.
PCT/US2003/006714 2002-03-28 2003-03-19 Novel secreted proteins and their uses Ceased WO2003083048A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP03745524A EP1492558A4 (en) 2002-03-28 2003-03-19 Novel secreted proteins and their uses
AU2003216525A AU2003216525A1 (en) 2002-03-28 2003-03-19 Novel secreted proteins and their uses

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36868802P 2002-03-28 2002-03-28
US60/368,688 2002-03-28

Publications (2)

Publication Number Publication Date
WO2003083048A2 WO2003083048A2 (en) 2003-10-09
WO2003083048A3 true WO2003083048A3 (en) 2004-04-01

Family

ID=28675529

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/006714 Ceased WO2003083048A2 (en) 2002-03-28 2003-03-19 Novel secreted proteins and their uses

Country Status (3)

Country Link
EP (1) EP1492558A4 (en)
AU (1) AU2003216525A1 (en)
WO (1) WO2003083048A2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020111302A1 (en) * 2000-11-30 2002-08-15 Y. Tom Tang Novel nucleic acids and polypeptides
US20030149238A1 (en) * 2000-02-14 2003-08-07 Pankaj Agarwal Novel compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000073448A1 (en) * 1999-05-27 2000-12-07 Zymogenetics, Inc. Adipocyte complement related protein homolog zacrp7
WO2003048326A2 (en) * 2001-12-03 2003-06-12 Nuvelo, Inc. Methods and materials relating to novel polypeptides and polynucleotides

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030149238A1 (en) * 2000-02-14 2003-08-07 Pankaj Agarwal Novel compounds
US20020111302A1 (en) * 2000-11-30 2002-08-15 Y. Tom Tang Novel nucleic acids and polypeptides

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE GENBANK [online] 20 December 2000 (2000-12-20), PIDDINGTON C.S. ET AL.: "Homo sapiens complement-c1q tumor necrosis factor-related protein", XP002972789, accession no. NCBI Database accession no. (AF329839) *
DATABASE GENBANK [online] 6 March 1999 (1999-03-06), STONE N.E. ET AL.: "Homo sapiens chromosome 4 clone C0478G20 map 4 q16", XP002972791, accession no. NCBI Database accession no. (AC007016) *
See also references of EP1492558A4 *

Also Published As

Publication number Publication date
WO2003083048A2 (en) 2003-10-09
AU2003216525A1 (en) 2003-10-13
EP1492558A2 (en) 2005-01-05
AU2003216525A8 (en) 2003-10-13
EP1492558A4 (en) 2006-07-19

Similar Documents

Publication Publication Date Title
WO2002014358A3 (en) Novel secreted proteins and their uses
WO2002008277A3 (en) Nucleic acids, vectors, host cells, polypeptides, and uses thereof
WO2005071088A3 (en) Recombinant nucleic acid molecules encoding fusion proteins comprising antigens and bacterial secretory signal polypeptides, expression cassettes, and bacteria, and methods of use thereof
WO2003027306A3 (en) Bgl3 beta-glucosidase and nucleic acids encoding the same
WO1999031236A3 (en) EXTENDED cDNAs FOR SECRETED PROTEINS
WO1999025825A3 (en) EXTENDED cDNAs FOR SECRETED PROTEINS
WO2004047863A3 (en) Genetic products differentially expressed in tumors and the use thereof
WO2001000806A3 (en) Dna's encoding proteins with signal peptides
WO2002059315A3 (en) Human nucleic acids and polypeptides and methods of use thereof
WO2002032939A3 (en) Secreted proteins and their uses
WO2005026205A3 (en) Genetic products which are differentially expressed in tumours and use thereof
WO2002102316A3 (en) Histone deacetylase and methods of use thereof
WO2001087978A3 (en) Human abc transporter and its use
WO2002026801A3 (en) Secreted proteins and their uses
WO2000008157A3 (en) Human anion transporter genes atnov
WO2002048361A3 (en) Novel secreted proteins and their uses
WO2002016578A3 (en) Secreted proteins and methods of using same
WO2001092493A3 (en) 21956 and 25856, human aminopeptidases and uses thereof
WO2002090500A3 (en) Novel human proteins, polynucleotides encoding them and methods of using the same
WO2004087886A3 (en) Modified adenoviral e1a constructs and methods of use thereof
WO2002012475A3 (en) C1q-related factor, homologous polypeptides and therapeutic uses thereof
WO2004013281A3 (en) Novel proteins and their uses
WO2003083048A3 (en) Novel secreted proteins and their uses
WO2003029778A3 (en) Novel secreted proteins and their uses
WO2004044126A3 (en) Novel proteins and their uses

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2003745524

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2003745524

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2003745524

Country of ref document: EP